baber/WOPTO huggingface dataset:
Patent JP-2001518815-A (JP)
Title: 歯科製品を製造しかつ情報を伝達する装置およびシステム
IPC: A61C13/00
Filed: 1998-03-19
Abstract: (57)【要約】
操作サイトは個々に設計された歯科製品、例えばディスタンシングピース類、ブリッジ類などを組み立てるために使用される。操作サイトはあご、象牙質、インプラントなどのシミュレートされたモデルおよびそのモデルに適用される構造部品を再生することができるコンピュータ装置が配置されている。操作サイトは組立体の一部に関する問合せプロフィルにデータを照合するために配置されている。問合せプロフィルデータをネットワークを介して中央ユニットに伝送するための部材が含められている。中央ユニットは問題の部分に関する情報を供給する。情報は操作サイトに送られるかまたは前記部分の製造のため中央ユニットに接続されている製造ユニットに送られる。デビッティングシステムは情報または製造それぞれに代価が払われたことを中央ユニットまたは製造サイトに示すために配置されている。
Patent JP-2001524233-A (JP)
Title: バーチャルプロパティシステム
IPC: G06F19/00
Filed: 1998-04-09
Abstract: (57)【要約】
プロパティ・オーナーシップ・転送システムは、コンピュータ・ネットワークと関連して使用することができる。このシステムは、限定エディションおよびデジタル・オブジェクトを創作し、価格を付けて交換することができる。
Patent JP-2000515833-A (JP)
Title: 加速度に対する防護服
IPC: A41D13/00
Filed: 1998-04-23
Abstract: (57)【要約】
本発明による衣服は、繊維性下着及び上着だけでなく、その間に位置する有効部分を備える。これは少なくとも一部が身体側の層（３）とそれとは反対側の層（４）とを備えて、どちらの層も流体密な低伸縮性繊維材料で製造され、接合、溶着、あるいは縫合により互いに接続位置（６）において接続されて、弁（１６，１７）により流体が充填される中空空間（５）を形成する。層（３，４）を備える領域、例えば上部（１４）及び正面部分（１５）の間には、張力のみを伝達する接合部分が配置される。これにより、この衣服を着用する身体の部分に瞬間的かつ部分的に作用する加速力に比例した補償圧力を形成して、このような加速による影響で起こるパイロットの人体組織から荷重を取り除く。この衣服は、ファスナ（１１，１２，１３）により閉塞し、面ファスナにより着用者の目下の身体的条件に整合させ、ファスナあるいは静水圧張力装置により張力をかけることができる。
Patent JP-2001508577-A (JP)
Title: ネットワークシステムのシステムデバイス動作状態表示方法
IPC: H04L12/40
Filed: 1999-05-03
Abstract: (57)【要約】
ネットワーク上に連結された多数台のデジタルデバイスが、ネットワーク通信階層上位にインターネットプロトコルスタックと同じプロトコル階層を有してクライアントまたはサーバの機能を遂行する時、クライアント機能を有するデバイスのディスプレー画面上に前記サーバ機能デバイスの動作状態変化を示すネットワークデバイスの動作状態変化表示方法は、クライアント機能のデバイス（以下、クライアントデバイス）がサーバ機能のデバイス（以下、サーバデバイス）と通信チャンネルを設定する第１段階と、サーバデバイスが所定動作を遂行している途中でその動作を止めたり他の動作を遂行したりする時、サーバデバイスから前記クライアントデバイスに動作状態変化を知らせる所定の信号を送信する第２段階と、クライアントデバイスが前記サーバデバイスから前記所定の信号を受信して自身の画面上に該当サーバデバイスの動作状態変化を示す第３段階とを具備する。これにより、使用者はネットワークに連結されたデバイスの動作状態変化を一デバイス画面を通じて分かってデバイス動作制御が効果的に遂行できる。
Patent NZ-208935-A (NZ)
Title: Carbamates and oxalamides of amino-n-(1h-tetrazol-5-yl)-benzamides
Inventor: PEET N P
IPC: C07D257/06
Filed: 1984-07-18
Abstract: Alkoxycarbonyl and oxalyl derivatives of amino-N-(1H-tetrazol-5-yl)benzamides are described herein. The compounds involved are useful as antiallergic agents. These compounds can be prepared by the reaction of an amino-N-(1H-tetrazol-5-yl)benzamide with an appropriate acid chloride.
Patent NZ-211144-A (NZ)
Title: Gas filter cartridge:support stays on outer side of filter material pleats
Inventor: MANNISO J L
IPC: B01D46/52
Filed: 1985-02-18
Abstract: @ A filter cartridge for removing particles or dust from a stream of moving gas or air, comprising a pleated filter medium (4) disposed between a pleated inner wire support frame (3), outer longitudinal wire support stays disposed along each inner apex of the pleats of the filter medium, and end caps. The outer wire stays (5) are formed from inwardly bent wires which are attached at each end to the inner frame (3) and exert pressure on the filter medium to support it against inner pressure of a pulse jet cleaning device. Preferred filter media are felt or fabric composites containing a layer of porous expanded polytetrafluoroethylene membrane.
Patent NZ-214154-A (NZ)
Title: Luteimizing hormone release hormone (lhrh) analogues
Inventor: NESTOR JOHN JOSEPH
IPC: C07K14/575
Filed: 1985-11-12
Abstract: Synthetic nonapeptide and decapeptide LHRH antagonist analogs having a halo lower alkyl guanadino-substituted amino acyl residue at position six are disclosed herein.
Patent NZ-222786-A (NZ)
Title: Electrostatic shield of dried conductive salt
Inventor: JONSSON SVEN
IPC: H01J29/89
Filed: 1987-12-02
Abstract: A method and an apparatus for reducing of and diverting radiation from all kinds of radiation emitting surfaces like viewing screens, TV screens, chassis, apparatus boxes etc. whereby an electrically conducting current diverting means (11), for instance a coil of stainless steel, is applied in direct contact with the radiation emitting surface (9) and is connected to earth (12), and whereby a fluid layer containing film or foil or a mass is applied directly to the radiation emitting surface (9) and the diverting means (11), said fluid layer or mass comprising a salt of electrolytic type, and in which the mass is of the type which forms a surface skin or becomes dried right through when being exposed to air, and said layer or mass being electrically conducting even in such dried state, and whereby the apparatus is ready for being used when said mass has formed a skin or has become dried. The current diverting means can be applied after the application of the electrolytic layer or mass. The fluid layer or covering mass preferably is a salt of an acid and an alkali metal or calcium, for instance sodium or potassium lauryl ether sulphate or calcium lauryl ether sulphate.
Patent NZ-222994-A (NZ)
Title: Condensed diazepinone derivatives and pharmaceutical compositions
Inventor: ENGEL WOLFHARD
IPC: C07D487/04
Filed: 1987-12-18
Abstract: There are described new condensed diazepinones of general formula <IMAGE>  (I)  wherein    &cir& B  represents one of the divalent groups   <IMAGE> +TR   <IMAGE>  and D represents the groups   <IMAGE> <IMAGE> +TR   <IMAGE>   and X1, X2 represents a =CH- group or, if &cir& B  assumes the meaning of the divalent group S, U or W, they may also represent an N atom, A1 and A2 in general represent lower alkylene groups, Z represents a C-C bond or the groups, -O-, -S-, -CH2-, or -(CH2)2-; R represents hydrogen or methyl, R1 and R2 generally represent alkyl groups which, together with the nitrogen atom between them, may also form a saturated monocylic, heterocyclic group, R3 represents alkyl, chlorine or hydrogen, R4 represents hydrogen or methyl, R5 and R6 represent hydrogen, halogen or alkyl, R7 represents hydrogen, chlorine or methyl, R8 represents hydrogen or lower alkyl, R9 represents hydrogen, halogen, lower alkyl and R10 represents hydrogen or methyl and R12 represents branched or unbranched alkyl. The compounds of general formula I and the acid addition salts thereof may be resolved into their isomers. The compounds of formula I and their salts may be used as vagal pacemakers for the treatment of bradycardia and bradyarrhythmia.
Patent NZ-232931-A (NZ)
Title: Process for preparing a flexographic relief printing plate
Inventor: TELSER THOMAS
IPC: C11D10/02
Filed: 1990-03-15
Abstract: A new liquid cleaner composition is provided for the mild and gentle removal of polymeric materials from sufaces without leaving any residues. The said new cleaner composition is an emulsion of the water-in-oil type comprising an aqueous phase finely dispersed in a continuous phase selected from the group consisting of nonflammable, fire-retardant, high-boiling, and fire-retardant and high-boiling organic phases, the volume ratio of the finely dispersed aqueous phase to the continuous organic phase being in the range of from 90:10 to 10:90. The new liquid cleaner composition can contain alcohols, surface-active agents and further useful additives. The new liquid cleaner composition is most preferably used in the process for preparing photopolymerized flexographic relief printing plates as the developer for washing out the non-irradiated and thus non-photopolymerized areas of the imagewise irradiated relief-forming recording layers of the said flexographic relief printing plates.
Patent NZ-240997-A (NZ)
Title: Preparation of n-mono- or n,n-disubstituted ureas
Inventor: ROSSLER MARKUS
IPC: C07C273/18
Filed: 1991-12-16
Abstract: Process for the preparation of N-mono- or N,N-disubstituted ureas by reacting ammonium isocyanate with a primary or secondary amine in a diluent.
Patent NZ-242044-A (NZ)
Title: A laminate comprising surface layers consisting mainly of polyolefin resin and an intermediate layer of butene-1-propylene copolymer
Inventor: TANAKA HARUHIKO
IPC: C08F210/08
Filed: 1992-03-18
Abstract: A laminate suitable for use as a food-packaging stretchable film comprises an intermediate layer (a) mainly comprising a butene-propylene copolymer, and an upper surface layer (b1) and a lower surface layer (b2) disposed on both sides of said intermediate layer (a), said surface layers mainly comprising a polyolefin resin (B).
Patent NZ-248202-A (NZ)
Title: Preparation of stable dry neem seed extract; insecticides
Inventor: LIDERT ZEV
IPC: A61K36/00
Filed: 1993-07-20
Abstract: A neem seed extract containing azadirachtin with improved stability has been developed using a process involving dissolution of the crude neem seed extract in a polar solvent and removal of impurities by precipitation and/or treatment of the extract with an oxidizing agent. The resulting extract, optionally formulated as a wettable powder, is a useful insecticide for the control of foliar pests.
Patent NZ-250414-A (NZ)
Title: Substituted 5'-deoxy-5-fluorocytidines and pharmaceutical compositions
Inventor: ARASAKI MOTOHIRO
IPC: A61K31/7068
Filed: 1993-12-10
Abstract: Compounds represented by the general formula (I), <CHEM> wherein R<1> is a saturated or unsaturated, straight or branched hydrocarbon radical [wherein the number of carbon atoms in the longest straight chain of this hydrocarbon radical ranges from three to seven], or a radical of the formula -(CH2)n-Y [in which n is an integer from 0 to 4, when Y is a cyclohexyl radical, or n is an integer from 2 to 4, when Y is a lower alkoxy radical having 1 to 4 carbon atom(s) or a phenyl radical], and R<2> is a hydrogen atom or a radical easily hydrolyzable under physiological conditions, as well as hydrates or solvates of the compounds of the general formula (I), can be utilized in the treatment of tumors, They can be prepared by reacting a compound of formula R<1>-OCOCl with a N<4>-unsubstituted 5'-deoxy-5-fluorocytidine of the above formula I, wherein R<2> would stand for protecting groups, and if necessary removing the protecting groups. <IMAGE>
Patent NZ-257031-A (NZ)
Title: Tropone substituted phenyloxazolidinone derivatives and anti-bacterial medicaments thereof
Inventor: BARBACHYN MICHAEL ROBERT
IPC: C07D263/38
Filed: 1993-10-14
Abstract: A novel class of phenyloxazolidinone antibacterial agents which have, as their salient structural feature, an appended substituted tropone moiety, are described. Intermediates and processes for the preparation of these antibiotics are also disclosed. These compounds are useful antibacterial agents to eradicate or control susceptible organisms.    <IMAGE>  I  wherein R4 is oxygen substituted heptatrienyl and R1, R2, and R3 are as defined herein.
Patent NZ-320568-A (NZ)
Title: Door control apparatus
Inventor: AGAM URI
IPC: E05F15/20
Filed: 1996-11-04
Abstract: A door control apparatus for vehicles includes at least one sensor (60, 62, 64) viewing at least one region (22) in the vicinity of a door (18) and logic circuitry responsive to said at least one sensor (60, 62, 64) for providing at least one region-clear output signal.  The apparatus also includes an automatic door opening and closing apparatus (24) responsive at least to the absence of said at least one region-clear output signal to cause opening of said door (18) and responsive at least to the presence of said at least one region-clear signal to cause closing of said door (18).
Patent NZ-330671-A (NZ)
Title: 13-Substituted-(Oxazolidin-4-yl)-oxycarbonyl-delta-6,7-taxols
Inventor: KELLY ROBERT C
IPC: C07D263/04
Filed: 1994-06-03
Abstract: he invention is related to a process of preparing a taxane compound of the formula (I) where the variables are as defined in the specification.  The process involves reacting an oxazolidine free acid with a baccatin in the presence of a dehydrating agent.
Patent NZ-332198-A (NZ)
Title: sustained release composition containing a gelling agent and 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-dibenzo[b,f][1, 4]-thiazepine
Inventor: PARIKH BHAVNISH VINOD
IPC: A61K47/26
Filed: 1997-05-27
Abstract: A sustained release formulation comprising a gelling agent and 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-dibenzo-[b,f][1,4]-thiazepine or a pharmaceutically acceptable salt thereof together with one or more pharmaceutically acceptable excipients is claimed.
Patent NZ-333062-A (NZ)
Title: Use of [R,S]-[2-(1H-indol-3-yl)-1-methyl-1-(1-phenyl-ethylcarbamoyl)-ethyl]-carbamic acid benzofuran-2yl methyl ester in the treatment of emesis
Inventor: HORWELL DAVID CHRISTOPHER
IPC: A61K31/405
Filed: 1997-06-18
Abstract: [R,S]-[2-(1H-indol-3-yl)-1-methyl-1-(1-phenyl-ethylcarbamoyl)-ethyl]-carbamic acid benzofuran-2-ylmethyl ester is used in the manufacture of a medicament for the treatment of emesis, motion sickness and post-operative nausea in a mammal.
Patent NZ-334644-A (NZ)
Title: Preassembled fitting for use with corrugated tubing
Inventor: ALBINO MARK
IPC: F16L19/04
Filed: 1998-06-15
Abstract: Provided is a fitting for corrugated tubing, such as flexible gas piping or corrugated stainless steel tubing, that is preassembled so that an installer can quickly and easily connect the fitting to the corrugated tubing.  Such a fitting comprises a body for including a conduit for providing access to the tubing; a nut connected to the body, the nut including an internal cavity; and a collet positioned within the cavity, the collet including a cylindrical body; a plurality of slots formed in the cylindrical body thereby defining a plurality of flexible collet sections; and a lip connected to the cylindrical body, the lip having an outer diameter greater than an outer diameter of the cylindrical body, the lip being received in a valley of the corrugated tubing. Figure 13 is a side view of corrugated tubing snapped into the fitting, and figure 14 is an enlarged view of a portion of the fitting once fully assembled.
Patent NZ-335125-A (NZ)
Title: Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
Inventor: PERKINS WALTER
IPC: A61K31/685
Filed: 1997-10-15
Abstract: Lipid-based carriers are provided herein that have a lamellar lipid component composed of an etherlipid and a complementarily shaped lipid. This novel combination of lipids allows for the incorporation of etherlipids in the carriers at higher concentrations than would otherwise be possible. Pharmaceutical compositions containing the carriers can be used therapeutically, for example, in the treatment of cancers.
Patent NZ-500177-A (NZ)
Title: Transurethral needle ablation device with replaceable stylet cartridge
Inventor: MCGAFFIGAN THOMAS H
IPC: A61B18/14
Filed: 1998-04-08
Abstract: A transurethral needle ablation device (31) is disclosed for use by a human hand to treat the prostate of a human male includes a cartridge assembly (33) having an elongate probe member (36) and a stylet (not shown).  The elongate probe member has proximal and distal extremities (36a, 36b) and is provided with a passageway (38) extending from the proximal extremity to the distal extremity.  The stylet is slidably mounted in the passageway of the elongate probe member.  A housing (121) is included in the device.  The cartridge assembly is removably mountable on the housing.  An assembly (146) adapted for actuation by the human hand is carried by the housing and coupled to the proximal extremity of the stylet for causing the distal extremity of the stylet to extend into the tissue of the prostate.
Patent NZ-500788-A (NZ)
Title: Vaginal lactobacillus medicant
Inventor: CHRISOPE GERALD L
IPC: A61K35/747
Filed: 1998-04-10
Abstract: Isolated strains of bacteria of the genus Lactobacillus which are useful in a vaginal medicament are disclosed. Also disclosed are medicaments containing such Lactobacilli, a  preservation matrix for microorganisms, a method for preserving microbial cells within a medicament, and methods for preventing and treating vaginal and gastrointestinal infections.
Patent NZ-500876-A (NZ)
Title: Method and apparatus for producing stretch wrap plastic film
Inventor: JOHNSTONE PETER
IPC: A01F25/13
Filed: 1998-05-01
Abstract: A plastics material film (1) is stretched beyond its yield point to about 100 % to 400 % elongation and thereafter only partially relaxed to release part of the elastic deformation component in the film to retain between about 20 % and 80 % of the elastic deformation in the film (1), the film thereafter being stored in this partially relaxed state whereby, when it is used, the retained elastic deformation capability is useable for the intended purpose of the film, for example, wrapping a load.
Patent NZ-504338-A (NZ)
Title: Substituted pyridine or piperidine compounds and pharmaceutical compositions
Inventor: METH-COHN OTTO
IPC: C07D213/36
Filed: 2000-05-04
Abstract: Compounds of formula (I) may be used in pharmaceutical compositions for the treatment of pain and memory deficiencies associated with cerebral ageing and neurodegenerative diseases such as Alzheimers disease, Parkinson's disease, Pick's disease, Korsakoff's disease and frontal lobe and subcortical dementias. In formula (I): A is a pyridine, pyridinium or piperidine group; R2 is H and R3 is OH, or R2 and R3 together form an oxo group; R4 is an optionally substituted phenyl group, an optionally substituted naphthyl group or an optionally substituted heteroaryl group; R1 is H, or R1 and R4, together with the two carbon atoms carrying them, form a ring containing 6 carbon atoms; or R1 and R2 form an additional bond, and in that case, R3 represents a 5- or 6- membered heterocycle that contains a nitrogen atom by which it is bound and that may contain another hetero atom selected from S, O and N; R5 is a 5- or 6- membered heterocycle that contains a nitrogen by which it is bonded to the ring A and that may contain another hetero atom, selected from S, O and N; or R5 is a group of formula (II), wherein R'1, R'2, R'3 and R'4 may have the same meanings as R1, R2, R3 and R4 respectively; or R5 is H, and in that case, R4 cannot represent an unsubstituted phenyl group, an unsubstituted naphthyl group or a heteroaryl group; and R6 is H or a linear or branched (C1-C6)-alkyl group, the group R6 being present or absent depending on the nature of the ring A.
Patent NZ-504996-A (NZ)
Title: Masonry render containing portland cement, plasterers lime, sand, graded stones, hydroxypropyl cellulose filaments and a silica based catalyst
Inventor: DE LOUB JUDITH CLARE
IPC: C04B24/24
Filed: 1998-11-04
Abstract: A dry masonry render mixture comprises:  20-36 % by weight of Portland cement; 1-3 % by weight of plasterers lime; 55-70 % by weight of washed sand; 0.02-0.35 % by weight of hydroxypropyl methylcellulose filaments and 0.5-3.5 % by weight of silica based catalyst. A dry masonry render mixture comprises:  20-38 % by weight of Portland cement; 1%-3 % by weight of plasterers lime; 48-70 % by weight of washed sand; 8-22 % by weight of microspheres of fused alumina silicate and 0.12 % by weight of hydroxypropyl methylcellulose filaments.  A dry masonry render comprises:  20-35 % by weight of Portland cement; 1-3 % by weight of plasterers lime; 45-65 % by weight of washed sand; 0.05-0.4 % by weight of hydroxypropyl methylcellulose filaments and 0.08-.05 % by weight of silica based catalyst The concentrations of the ingredients of the above renders can be varied to achieve different finishes.  The above renders can also contain a cement plasticiser and graded stones having 1.5-3.0mm diameter The ingredients mixed in the presence of filaments and silica based catalyst.  The dry render masonry mixture is mixed with a liquid solution of water and a latex polymer of various concentrations to form a slurry.  Methods of application of varying concentrations of the slurry to obtain different textured finishes are described.
Patent NZ-505857-A (NZ)
Title: Silicate-containing powders providing controlled, sustained gas release
Inventor: WELLINGHOFF STEPHEN T
IPC: A61K33/20
Filed: 1999-02-01
Abstract: A particle comprising anions dissolved in an amorphous, paracrystalline solid solution, the anions being capable of reacting with hydronium ions to generate a gas. The particle can be incorporated into a powder capable of generating and releasing a gas after the hydrolysis of an acid releasing agent.
Patent NZ-506384-A (NZ)
Title: An alcoholic cream comprising a gelling agent
Inventor: MICHAEL LAURENCE MURPHY
IPC: A23L29/20
Filed: 2000-08-16
Abstract: An edible alcoholic composition comprising cream and a fluid gelling agent, otherwise known as a cream liqueur.
Patent NZ-508395-A (NZ)
Title: A composition comprising HMB and at least one amino acid for increasing lean tissue mass without concomitant decrease in fat mass
Inventor: NISSEN STEVEN L
IPC: A61K31/197
Filed: 1999-06-23
Abstract: A transgenic mouse whose somatic and germ cells have  a substantial   deficiency  in  the  corticotropin   releasing factor  receptor-1,  wherein one  or  both  alleles  of  the corticotropin  releasing  factor  receptor-1  are  disrupted resulting  in  a  mouse  with  decreased  anxiety,   reduced endocrine response to stress and altered locomoter  activity rhythms  as  compared to a control mouse.  Also covered  are methods  of  using said mouse for identifying  agonists  and antagonists of corticotropin releasing factor, urocortin  or related  ligands  that  act  through  receptors  other  than corticotropin  releasing factor receptor-1,  offspring  from said  mouse,  using  offspring from  said  mouse  to  screen compounds   that   are   analogs   of   corticosterone    or corticotropin  and  a  method of producing  said  transgenic mouse.
Patent NZ-510321-A (NZ)
Title: Anchor element with hollow screw-in anchor and plug, with anchor filled with grout
Inventor: ANDERSON DALE
IPC: E02D5/80
Filed: 2001-03-05
Abstract: A method of casting an in-ground column by inserting a hollow screw-in ground anchor into the ground and filling the hollow interior of the anchor (64) with grout (65).  The apparatus for carrying out the method described above comprising a hollow, screw-in anchor having a plug at the leading end and an entry at the trailing end for the admission of fluent grout to the hollow interior.
Patent NZ-510556-A (NZ)
Title: General epoxidation reaction for compounds with olefinic double bonds especially for synthesis for epoxymexrenone
Inventor: NG JOHN S
IPC: C07J41/00
Filed: 1997-12-11
Abstract: A compound of formula 301, 302, 303, 304, 305, 306, 307, 308 or 309 wherein: R1 is an alpha-oriented alkoxycarbonyl or hydroxycarbonyl radical; -A-A- is the group -CHR4-CHR5- or -CR4=CR5-; R3, R4 and R5 are independently hydrogen, halo, hydroxy, alkyl, alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxy carbonyl, cyano or aryloxy; -B-B- is the group -CHR6-CHR7- or an alpha or beta- oriented group of formula III; R6 and R7 are independently hydrogen, halo, alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano or aryloxy; and R8 and R9 are independently hydrogen, hydroxy, halo, alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano or aryloxy, or together comprise a carbocyclic or heterocyclic ring structure, or R8 or R9 together with R6 or R7 comprise a carbocyclic or heterocyclic ring structure fused to the pentacyclic D ring.
Patent NZ-512536-A (NZ)
Title: Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
Inventor: KELLER BRADLEY T
IPC: A61K31/4995
Filed: 1999-12-17
Abstract: Described are combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. The combinations disclosed include an ileal bile acid transport inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor.
Patent NZ-512609-A (NZ)
Title: Synthetic sweeteners, their production and uses thereof
Inventor: YAMAGUCHI HISAMI
IPC: A61K/
Filed: 1997-02-21
Abstract: A   synthetic  sweetener  selected  from  the   group consisting  of  saccharin or a salt  thereof,  and  cyclamic acid  or  a salt thereof, each of which is produced  by  wet granulation  or  dry granulation, and has  a  mean  particle size of not less than 150 um.